Medindia LOGIN REGISTER
Medindia
Advertisement

WorldHeart Announces Delisting Appeal Received and Will be Considered at Hearing July 10, 2008

Wednesday, May 28, 2008 General News
Advertisement
OAKLAND, Calif., May 27 (Nasdaq: WHRT, TSX: WHT)-- World Heart Corporation (the "Company") today announced that on May 20,2008, it had received a letter from the NASDAQ Hearings Panel stating thatthey had received the Company's request to appeal the NASDAQ ListingQualification Staff determination to delist World Heart Corporation'ssecurities from the NASDAQ Stock Market. Accordingly, the delisting actionreferenced in the NASDAQ Staff's determination letter has been stayed, pendinga final written decision by the NASDAQ Hearings Panel.
Advertisement

This letter provided formal notice that the panel will consider our appealat an oral/written hearing. The hearing will be held on Thursday, July 10,2008, at 2:30 PM in Washington, DC.
Advertisement

This decision by the NASDAQ Hearings Panel means that the stock willcontinue to trade at least until the determination is made at this hearing.

About World Heart Corporation

WorldHeart is a developer of mechanical circulatory support systems. TheCompany is headquartered in Oakland, California, USA with additionalfacilities in Salt Lake City, Utah and Herkenbosch, Netherlands. WorldHeart'sregistered office is Ottawa, Ontario, Canada.

Any forward-looking statements in this release are made pursuant to thesafe harbor provisions of the Private Securities Litigation Reform Act of 1995and include any statements regarding the Company's ability to regaincompliance with the NASDAQ Capital Market listing requirements, as well asother statements that can be identified by the use of forward-lookinglanguage, such as "believes," "feels," "expects," "may," "will," "should,""seeks," "plans," "anticipates," or "intends" or the negative of those terms,or by discussions of strategy or intentions. Investors are cautioned that allforward-looking statements involve risk and uncertainties, including withoutlimitation: the Company's immediate need for additional capital, risks inproduct development and market acceptance of and demand for the Company'sproducts; delisting from the NASDAQ Stock Market if compliance with thelisting standards, including the Minimum Bid Price Rule and other minimumstandards, is not regained; and other risks detailed in the Corporation'sfilings with the U.S. Securities and Exchange Commission, including withoutlimitation its Annual Report on Form 10-KSB for the year ended December 31,2007.

SOURCE World Heart Corporation
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close